Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jørn Brynskov

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
The American Journal of Gastroenterology|January 21, 2010
Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activityGitte Pedersen, Jørn Brynskov
Ugeskrift for Laeger|June 19, 2004
[Gene mutations connected to Crohn disease]Mads Wichmann Matthiessen, Jørn Brynskov
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2021
ReplyCasper Steenholdt, Jørn Brynskov, Peter Vilmann
The American Journal of Gastroenterology|November 22, 2007
Tumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's diseaseMark A Ainsworth, Klaus Bendtzen, Jørn Brynskov
The American Journal of Gastroenterology|January 5, 2022
Herpes Zoster Meningoencephalitis: A Novel, Rare, Potentially Fatal Side Effect to TofacitinibCasper Steenholdt, Lars Erik Kristensen, Jørn Brynskov
Scandinavian Journal of Gastroenterology|April 12, 2015
Clinical outcome of adalimumab therapy in patients with ulcerative colitis previously treated with infliximab: a Danish single-center cohort studyKatrine Risager Christensen, Casper Steenholdt, Jørn Brynskov
European Journal of Gastroenterology & Hepatology|March 23, 2026
Chest X-ray prior to biological treatment in inflammatory bowel diseases: it is not only about tuberculosis - a case report and literature reviewIda Malene Hagbard Binder, Jørn Brynskov, Mohamed Attauabi
Scandinavian Journal of Gastroenterology|August 13, 2010
Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experienceAne Søgaard Teisner, Mark A Ainsworth, Jørn Brynskov
Inflammatory Bowel Diseases|May 3, 2016
Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug AntibodiesCasper Steenholdt, Klaus Bendtzen, Jørn Brynskov, et al.
Scandinavian Journal of Gastroenterology|November 6, 2008
Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel diseaseCasper Steenholdt, Lars Andresen, Gitte Pedersen, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
The American Journal of Gastroenterology|January 21, 2010
Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activityGitte Pedersen, Jørn Brynskov
Ugeskrift for Laeger|June 19, 2004
[Gene mutations connected to Crohn disease]Mads Wichmann Matthiessen, Jørn Brynskov
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2021
ReplyCasper Steenholdt, Jørn Brynskov, Peter Vilmann
The American Journal of Gastroenterology|November 22, 2007
Tumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's diseaseMark A Ainsworth, Klaus Bendtzen, Jørn Brynskov
The American Journal of Gastroenterology|January 5, 2022
Herpes Zoster Meningoencephalitis: A Novel, Rare, Potentially Fatal Side Effect to TofacitinibCasper Steenholdt, Lars Erik Kristensen, Jørn Brynskov
Scandinavian Journal of Gastroenterology|April 12, 2015
Clinical outcome of adalimumab therapy in patients with ulcerative colitis previously treated with infliximab: a Danish single-center cohort studyKatrine Risager Christensen, Casper Steenholdt, Jørn Brynskov
European Journal of Gastroenterology & Hepatology|March 23, 2026
Chest X-ray prior to biological treatment in inflammatory bowel diseases: it is not only about tuberculosis - a case report and literature reviewIda Malene Hagbard Binder, Jørn Brynskov, Mohamed Attauabi
Scandinavian Journal of Gastroenterology|August 13, 2010
Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experienceAne Søgaard Teisner, Mark A Ainsworth, Jørn Brynskov
Inflammatory Bowel Diseases|May 3, 2016
Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug AntibodiesCasper Steenholdt, Klaus Bendtzen, Jørn Brynskov, et al.
Scandinavian Journal of Gastroenterology|November 6, 2008
Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel diseaseCasper Steenholdt, Lars Andresen, Gitte Pedersen, et al.
Pageof 7